| Patient | Robert Peary |
|---|---|
| Date of birth | 1963-05-06 |
| Identifiers | MRN HR-EX004-SYN; SSN (made up) 000-04-7351 |
| Document date | 2026-01-13 |
| Author | Thaddeus Lindgren-Okafor, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for establishing primary care for four months of fatigue, breathlessness, pallor, a sore tongue, and numbness and unsteadiness in the feet: blood tests, neurological and foot examination, falls, mood, the first vitamin B12 injection and a hematology consultation. [S]
Hemoglobin: 8.2 g/dL (low); MCV: 118 fL (high); RDW: 19.6% (high); White blood cells: 3.4 10*3/uL (low); Platelets: 118 10*3/uL (low); Reticulocytes: 0.4% (low); LDH: 1240 U/L (high); Total bilirubin: 1.9 mg/dL (high); Sodium: 139 mmol/L; Potassium: 4.1 mmol/L; Creatinine: 0.98 mg/dL; eGFR: 85 mL/min/1.73 m²; Glucose: 92 mg/dL; Vitamin B12: 96 pg/mL (low); Folate: 14.2 ng/mL; Methylmalonic acid: 3.1 umol/L (high); Homocysteine: 38 umol/L (high); Ferritin: 62 ng/mL; Iron: 148 ug/dL; TIBC: 268 ug/dL; Transferrin saturation: 55% (high); TSH: 2.6 mIU/L; HbA1c: 5.5%; PHQ-9: 6; MoCA: 27; AUDIT-C: 2. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-01-13 | Body height | 183 | cm | S |
| 2026-01-13 | Body weight | 72.4 | kg | S |
| 2026-01-13 | Body mass index (BMI) [Ratio] | 21.6 | kg/m2 | S |
| 2026-01-13 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-01-13 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 2026-01-13 | Heart rate | 102 | /min | S |
| 2026-01-13 | Respiratory rate | 18 | /min | S |
| 2026-01-13 | Body temperature | 36.7 | Cel | S |
| 2026-01-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-01-13 | Hemoglobin [Mass/volume] in Blood | 8.2 | g/dL | 13.2-17.1 g/dL | Low | S |
| 2026-01-13 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 118 | fL | 80-100 fL | High | S |
| 2026-01-13 | Erythrocyte [DistWidth] in Blood by Automated count | 19.6 | % | 11-15% | High | S |
| 2026-01-13 | Leukocytes [#/volume] in Blood by Automated count | 3.4 | 10*3/uL | 3.8-10.8 10*3/uL | Low | S |
| 2026-01-13 | Platelets [#/volume] in Blood by Automated count | 118 | 10*3/uL | 140-400 10*3/uL | Low | S |
| 2026-01-13 | Reticulocytes/Erythrocytes in Blood by Automated count | 0.4 | % | 0.5-2.5% | Low | S |
| 2026-01-13 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma | 1240 | U/L | 120-250 U/L | High | S |
| 2026-01-13 | Bilirubin.total [Mass/volume] in Serum or Plasma | 1.9 | mg/dL | 0.2-1.2 mg/dL | High | S |
| 2026-01-13 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-146 mmol/L | Normal | S |
| 2026-01-13 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.3 mmol/L | Normal | S |
| 2026-01-13 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.7-1.3 mg/dL | Normal | S |
| 2026-01-13 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 85 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-01-13 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 65-99 mg/dL | Normal | S |
| 2026-01-13 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 96 | pg/mL | 200-1100 pg/mL | Low | S |
| 2026-01-13 | Folate [Mass/volume] in Serum or Plasma | 14.2 | ng/mL | >=5.4 ng/mL | Normal | S |
| 2026-01-13 | Methylmalonate [Moles/volume] in Serum or Plasma | 3.1 | umol/L | <=0.4 umol/L | High | S |
| 2026-01-13 | Homocysteine [Moles/volume] in Serum or Plasma | 38 | umol/L | <=15 umol/L | High | S |
| 2026-01-13 | Ferritin [Mass/volume] in Serum or Plasma | 62 | ng/mL | 30-400 ng/mL | Normal | S |
| 2026-01-13 | Iron [Mass/volume] in Serum or Plasma | 148 | ug/dL | 50-180 ug/dL | Normal | S |
| 2026-01-13 | Iron binding capacity [Mass/volume] in Serum or Plasma | 268 | ug/dL | 250-425 ug/dL | Normal | S |
| 2026-01-13 | Iron saturation [Mass Fraction] in Serum or Plasma | 55 | % | 20-50% | High | S |
| 2026-01-13 | Thyrotropin [Units/volume] in Serum or Plasma | 2.6 | m[IU]/L | 0.4-4.5 mIU/L | Normal | S |
| 2026-01-13 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5 | % | <=5.6% | Normal | S |
| 2026-01-13 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S | ||
| 2026-01-13 | Total score [MoCA] | 27 | {score} | S | ||
| 2026-01-13 | Total score [AUDIT-C] | 2 | {score} | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Cyanocobalamin (vitamin B12) 1,000 micrograms (1 mg/mL) intramuscular injection every other day for seven doses, given by the clinic nurse after the intake blood tests were drawn | 1,000 micrograms into the muscle every other day, seven doses | Intramuscular route | 2026-01-13 to 2026-01-25 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Fatigue, breathlessness on exertion, pallor with a lemon-yellow tinge, a sore tongue, and numbness and unsteadiness in the feet over about four months, with a macrocytic anemia, low white cells and platelets, a low vitamin B12 and a high methylmalonic acid; cause under evaluation with a hematology consultation | active | confirmed | D51.9 | S — Synthetic presenting problem anchored to the documented pernicious anemia of his last years; superseded when the consultation confirmed pernicious anemia. |
| Subacute combined degeneration of the spinal cord with peripheral neuropathy from vitamin B12 deficiency: loss of vibration and joint position sense in the feet, absent ankle jerks, brisk knee jerks and a positive Romberg test | active | confirmed | G32.0 | S — Synthetic neurological complication; not a claim about his real nerves. |
| Absence of the second to fifth toes of the right foot after frostbite and amputation in early middle age; healed stumps; callus under the first metatarsal head | active | confirmed | Z89.421 | S — Synthetic modern coding of his documented toe amputations; the count of toes is synthetic (CLM-0007). |
| Absence of the second to fifth toes of the left foot after frostbite and amputation in early middle age; healed stumps | active | confirmed | Z89.422 | S — Synthetic modern coding of his documented toe amputations; the count of toes is synthetic (CLM-0007). |
| One fall in a dark bedroom a month ago without injury; unsteady in the dark and on uneven ground; uses a stick outdoors | active | confirmed | Z91.81 | S — Synthetic fall linked to the neuropathy and the old toe amputations. |